Features
- Cardioncology Aiming for Respect as Multidisciplinary Specialty
- Califf for Commish? Opposition Rocks Senate Confirmation Process
- Bring Back LDL Targets, Says CVS on Advent of PCSK9 Inhibitors
- What Now, ARNI? Experts Ponder Newly Arrived Heart-Failure Drug
- 'Guarded Enthusiasm' Builds for PCSK9 Inhibitors
- Ivabradine (Corlanor) US Approval for HF 'Out of the Blue'
- Protecting Physicians: Staff Safety Highlighted With Boston Shooting
- Crowdsource the Integrity of Published CV Research? A Debate
- Dosing the NOACs in Atrial Fib: Can We Do Better?
- Who's Watching? The Case for a Live Case Outcomes Registry
- HFSA Penalizing 'Excess' HF Readmissions: Incentive or Distraction?
- HFSA Penalizing "Excess' HF Readmissions: Incentive or Distraction?
- Heart-smart diabetes drugs: Pipedream or possibility?
- JNC 8, ATP 4 Guidelines (Still) Soon to Be Released
- Single-Drug Polypharmacy in Cardiovascular Disease
- Preventing Sudden Cardiac Death at the 2012 Olympic Games
- Multibiomarker inflammation test for heart risk prediction
- So Long, Plavix, What a Ride! Clopidogrel Patent Expires
- Seeking Community in the LVAD Age
- Statin safety: Cardiologists respond to FDA's glucose, cognition warnings